Concepedia

Ch. Bruns

CB

Statistics

Publications

6

Citations

828

H-Index

6

Active since

1992

Affiliations

Novartis (Switzerland)(Current)

Ch. Bruns is an author at Novartis (Switzerland) specializing in medicine, somatostatin analogues, and endocrine nuclear medicine.

Publications per year

1992–2003

6

Publications

6

Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.

E. P. Krenning, WH Bakker, P P Kooij et al. · PubMed · 1992 · 422 citations

, , +16

Sandostatin LAR in Acromegalic Patients: Long Term Treatment

A K Fløgstad, Johan Halse, S. J. Bakke et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 177 citations · Full text

, , +15

sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells.

Nathalie Delesque, Louis Buscail, J.P. Estève et al. · PubMed · 1997 · 105 citations

, , +13

Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219?387) labelled with technetium-99m

Barbara Stolz, Rainer Albert, Ch. Bruns · European Journal of Nuclear Medicine and Molecular Imaging · 1994 · 78 citations

, , +13

New insights on SOM230, a universal somatostatin receptor ligand.

Viktor Boerlin, Joost van der Hoek, C Beglinger et al. · PubMed · 2003 · 35 citations

, , +6

1–5 of 6